CAS announces the participants selected for the 2025 CAS Future Leaders program

CAS announces the participants selected for the 2025 CAS Future Leaders program

The esteemed initiative equips early-career scientists with leadership training and networking opportunities COLUMBUS, Ohio, March 20, 2025 /PRNewswire/ -- CAS, a division of the American Chemical Society (ACS) specializing in scientific knowledge...

HUYA Inc. Announces Ex-dividend Date for Recently Announced Cash Dividend

HUYA Inc. Announces Ex-dividend Date for Recently Announced Cash Dividend

GUANGZHOU, China, March 20, 2025 /PRNewswire/ -- HUYA Inc. ("Huya" or the "Company") (NYSE: HUYA), a leading game live streaming platform in China, today announced that the New York Stock Exchange ("NYSE") has set July 1, 2025 as the ex-dividend...

Baozun Announces Fourth Quarter and Fiscal Year 2024 Unaudited Financial Results

Baozun Announces Fourth Quarter and Fiscal Year 2024 Unaudited Financial Results

SHANGHAI, March 20, 2025 /PRNewswire/ -- Baozun Inc. (Nasdaq: BZUN and HKEX: 9991) ("Baozun", the "Company" or the "Group"), a leading brand e-commerce solution provider and digital commerce enabler in China, today announced its unaudited financial...

Nobu Hospitality Announces Nobu Hotel, Restaurant, and Residences Manchester and the First Residential Project in the UK

Nobu Hospitality Announces Nobu Hotel, Restaurant, and Residences Manchester and the First Residential Project in the UK

NEW YORK, March 20, 2025 /PRNewswire/ -- Nobu Hospitality, the globally recognised luxury lifestyle brand, has unveiled plans for a landmark development in Manchester, featuring a hotel, restaurant, and the UK's first Nobu-branded residences. In...

Marriott Bonvoy Announces Its Partnership with Hong Kong's Kai Tak Sports Park as the Exclusive Founding Hotel Partner

Marriott Bonvoy Announces Its Partnership with Hong Kong's Kai Tak Sports Park as the Exclusive Founding Hotel Partner

HONG KONG, March 20, 2025 /PRNewswire/ -- Marriott Bonvoy, Marriott International's award-winning travel loyalty program, today announced a multi-year agreement with Kai Tak Sports Park (KTSP), Hong Kong's largest sports and entertainment landmark....

111, Inc. Announces Fourth Quarter and Fiscal Year 2024 Financial Results

111, Inc. Announces Fourth Quarter and Fiscal Year 2024 Financial Results

Achieved First-Ever Annual Operating Profit Bottom Line Improved by RMB332.7 Million YoY in 2024 Operating Expenses as a Percentage of Revenues Decreased 230 Basis Points YoY in 2024 Q4'24 Operating Expenses as a Percentage of Revenues Decreased 470...

Announcing the Multilingual Conversational Speech Language Model (MLC-SLM) Challenge

Announcing the Multilingual Conversational Speech Language Model (MLC-SLM) Challenge

MONROVIA, Calif., March 19, 2025 /PRNewswire/ -- Nexdata, a leading global provider of AI data services today announces the start of The Multilingual Conversational Speech LLM (MLC-SLM) Challenge, an officially approved satellite event of...

Porton Advanced Announces Collaboration with Eureka Therapeutics to Accelerate T‑Cell Therapy Development

Porton Advanced Announces Collaboration with Eureka Therapeutics to Accelerate T‑Cell Therapy Development

CRANBURY, N.J., March 19, 2025 /PRNewswire/ -- Porton Advanced, a leading contract development and manufacturing organization (CDMO) specializing in advanced therapy medicinal products (ATMPs), is pleased to announce its partnership with Eureka...

Alamar Biosciences Announces First Five Distribution Partners, Expanding Commercial Support in Asia Pacific

Alamar Biosciences Announces First Five Distribution Partners, Expanding Commercial Support in Asia Pacific

FREMONT, Calif., March 19, 2025 /PRNewswire/ -- Alamar Biosciences, a company powering precision proteomics to enable the earliest detection of disease, is pleased to announce the signing of five new distribution partners to expand its global...

Jacobio Pharma Announces 2024 Annual Results

Jacobio Pharma Announces 2024 Annual Results

BEIJING, SHANGHAI and BOSTON, March 19, 2025 /PRNewswire/ -- Jacobio Pharma (1167.HK) released its 2024 annual results, with revenue of RMB160 million, R&D expense of RMB330 million. Major operating and financing activities generated RMB320...

  • 1
  • ...
  • 23
  • 24
  • 25
  • 26
  • 27
  • 28
  • 29
  • 30
  • 31
  • ...
  • 85
  • menu
    menu